These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 12614684

  • 1. Mecamylamine interactions with galantamine and donepezil: effects on learning, acetylcholinesterase, and nicotinic acetylcholine receptors.
    Woodruff-Pak DS, Vogel RW, Wenk GL.
    Neuroscience; 2003; 117(2):439-47. PubMed ID: 12614684
    [Abstract] [Full Text] [Related]

  • 2. Preclinical investigation of the functional effects of memantine and memantine combined with galantamine or donepezil.
    Woodruff-Pak DS, Tobia MJ, Jiao X, Beck KD, Servatius RJ.
    Neuropsychopharmacology; 2007 Jun; 32(6):1284-94. PubMed ID: 17119537
    [Abstract] [Full Text] [Related]

  • 3. Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors.
    Barnes CA, Meltzer J, Houston F, Orr G, McGann K, Wenk GL.
    Neuroscience; 2000 Jun; 99(1):17-23. PubMed ID: 10924948
    [Abstract] [Full Text] [Related]

  • 4. Galantamine and donepezil differently affect isolation rearing-induced deficits of prepulse inhibition in mice.
    Koda K, Ago Y, Kawasaki T, Hashimoto H, Baba A, Matsuda T.
    Psychopharmacology (Berl); 2008 Feb; 196(2):293-301. PubMed ID: 17912499
    [Abstract] [Full Text] [Related]

  • 5. Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits.
    Geerts H, Guillaumat PO, Grantham C, Bode W, Anciaux K, Sachak S.
    Brain Res; 2005 Feb 08; 1033(2):186-93. PubMed ID: 15694923
    [Abstract] [Full Text] [Related]

  • 6. Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors.
    Arias E, Gallego-Sandín S, Villarroya M, García AG, López MG.
    J Pharmacol Exp Ther; 2005 Dec 08; 315(3):1346-53. PubMed ID: 16144975
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of purinergic neurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vas deferens.
    Caricati-Neto A, D'angelo LC, Reuter H, Hyppolito Jurkiewicz N, Garcia AG, Jurkiewicz A.
    Eur J Pharmacol; 2004 Oct 25; 503(1-3):191-201. PubMed ID: 15496314
    [Abstract] [Full Text] [Related]

  • 8. Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning.
    Woodruff-Pak DS, Vogel RW, Wenk GL.
    Proc Natl Acad Sci U S A; 2001 Feb 13; 98(4):2089-94. PubMed ID: 11172080
    [Abstract] [Full Text] [Related]

  • 9. Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors.
    Schilström B, Ivanov VB, Wiker C, Svensson TH.
    Neuropsychopharmacology; 2007 Jan 13; 32(1):43-53. PubMed ID: 16641937
    [Abstract] [Full Text] [Related]

  • 10. Galantamine ameliorates the impairment of recognition memory in mice repeatedly treated with methamphetamine: involvement of allosteric potentiation of nicotinic acetylcholine receptors and dopaminergic-ERK1/2 systems.
    Noda Y, Mouri A, Ando Y, Waki Y, Yamada SN, Yoshimi A, Yamada K, Ozaki N, Wang D, Nabeshima T.
    Int J Neuropsychopharmacol; 2010 Nov 13; 13(10):1343-54. PubMed ID: 20219155
    [Abstract] [Full Text] [Related]

  • 11. Galantamine improves apomorphine-induced deficits in prepulse inhibition via muscarinic ACh receptors in mice.
    Yano K, Koda K, Ago Y, Kobayashi H, Kawasaki T, Takuma K, Matsuda T.
    Br J Pharmacol; 2009 Jan 13; 156(1):173-80. PubMed ID: 19133998
    [Abstract] [Full Text] [Related]

  • 12. Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice.
    Csernansky JG, Martin M, Shah R, Bertchume A, Colvin J, Dong H.
    Neuropsychopharmacology; 2005 Dec 13; 30(12):2135-43. PubMed ID: 15956997
    [Abstract] [Full Text] [Related]

  • 13. Comparison of galantamine and donepezil for effects on nerve growth factor, cholinergic markers, and memory performance in aged rats.
    Hernandez CM, Gearhart DA, Parikh V, Hohnadel EJ, Davis LW, Middlemore ML, Warsi SP, Waller JL, Terry AV.
    J Pharmacol Exp Ther; 2006 Feb 13; 316(2):679-94. PubMed ID: 16214877
    [Abstract] [Full Text] [Related]

  • 14. Nicotinic modulation in an animal model of a form of associative learning impaired in Alzheimer's disease.
    Woodruff-Pak DS, Santos IS.
    Behav Brain Res; 2000 Aug 13; 113(1-2):11-9. PubMed ID: 10942028
    [Abstract] [Full Text] [Related]

  • 15. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.
    Wilkinson DG, Francis PT, Schwam E, Payne-Parrish J.
    Drugs Aging; 2004 Aug 13; 21(7):453-78. PubMed ID: 15132713
    [Abstract] [Full Text] [Related]

  • 16. The allosteric potentiation of nicotinic acetylcholine receptors by galantamine is transduced into cellular responses in neurons: Ca2+ signals and neurotransmitter release.
    Dajas-Bailador FA, Heimala K, Wonnacott S.
    Mol Pharmacol; 2003 Nov 13; 64(5):1217-26. PubMed ID: 14573772
    [Abstract] [Full Text] [Related]

  • 17. Acquisition and reinstatement of ethanol-induced conditioned place preference in rats: Effects of the cholinesterase inhibitors donepezil and rivastigmine.
    Gawel K, Labuz K, Gibula-Bruzda E, Jenda M, Marszalek-Grabska M, Silberring J, Kotlinska JH.
    J Psychopharmacol; 2016 Jul 13; 30(7):676-87. PubMed ID: 27097732
    [Abstract] [Full Text] [Related]

  • 18. Adjunctive galantamine, but not donepezil, enhances the antipsychotic-like effect of raclopride in rats.
    Wiker C, Schilström B, Sandbäck C, Wadenberg ML, Svensson TH.
    Int J Neuropsychopharmacol; 2008 Sep 13; 11(6):845-50. PubMed ID: 18405415
    [Abstract] [Full Text] [Related]

  • 19. Additive protective effects of donepezil and nicotine against salsolinol-induced cytotoxicity in SH-SY5Y cells.
    Das JR, Tizabi Y.
    Neurotox Res; 2009 Oct 13; 16(3):194-204. PubMed ID: 19526284
    [Abstract] [Full Text] [Related]

  • 20. Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors.
    Samochocki M, Höffle A, Fehrenbacher A, Jostock R, Ludwig J, Christner C, Radina M, Zerlin M, Ullmer C, Pereira EF, Lübbert H, Albuquerque EX, Maelicke A.
    J Pharmacol Exp Ther; 2003 Jun 13; 305(3):1024-36. PubMed ID: 12649296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.